You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

BETAPACE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Betapace patents expire, and what generic alternatives are available?

Betapace is a drug marketed by Legacy Pharma and is included in two NDAs.

The generic ingredient in BETAPACE is sotalol hydrochloride. There are ten drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the sotalol hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Betapace

A generic version of BETAPACE was approved as sotalol hydrochloride by TEVA on May 1st, 2000.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for BETAPACE?
  • What are the global sales for BETAPACE?
  • What is Average Wholesale Price for BETAPACE?
Summary for BETAPACE
Drug patent expirations by year for BETAPACE
Drug Prices for BETAPACE

See drug prices for BETAPACE

Drug Sales Revenue Trends for BETAPACE

See drug sales revenues for BETAPACE

Recent Clinical Trials for BETAPACE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Xinhua Hospital, Shanghai Jiao Tong University School of MedicinePhase 4
Medtronic (Shanghai) Management Co. Ltd.Phase 4
Beijing CTSmed Co. LtdPhase 4

See all BETAPACE clinical trials

Pharmacology for BETAPACE
Drug ClassAntiarrhythmic
Mechanism of ActionAdrenergic beta-Antagonists
Physiological EffectCardiac Rhythm Alteration

US Patents and Regulatory Information for BETAPACE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Legacy Pharma BETAPACE sotalol hydrochloride TABLET;ORAL 019865-001 Oct 30, 1992 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Legacy Pharma BETAPACE AF sotalol hydrochloride TABLET;ORAL 021151-007 Apr 2, 2003 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Legacy Pharma BETAPACE sotalol hydrochloride TABLET;ORAL 019865-003 Oct 30, 1992 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Legacy Pharma BETAPACE AF sotalol hydrochloride TABLET;ORAL 021151-001 Feb 22, 2000 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Legacy Pharma BETAPACE sotalol hydrochloride TABLET;ORAL 019865-005 Apr 20, 1994 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Legacy Pharma BETAPACE sotalol hydrochloride TABLET;ORAL 019865-002 Oct 30, 1992 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.